Composition of antigen and glycolipid adjuvant for sublingual administration
US8470331B2 · kind B2 · utility
0Cited by
17References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 15, 2001 |
| Grant date | Jun 25, 2013 |
| Priority date | — |
| Expiry date | Aug 23, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/57
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of producing a mucosal and systemic immune response in a mammal comprising administering sublingually an effective amount of a composition comprising at least one antigen and a glycolipid adjuvant to said mammal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.